Prognostic impact of PD-1 and its ligands in renal cell carcinoma
- 21 April 2017
- journal article
- review article
- Published by Springer Nature in Medical Oncology
- Vol. 34 (6) , 1-8
Abstract
Programmed death-1 receptor (PD-1) and programmed death-1 receptor-ligand (PD-L1) have been suggested to play a role as prognostic markers in clear cell renal cell carcinoma (ccRCC). The association between PD-L1 and prognosis seems to be more robust than for PD-1. Further, preliminary analyses suggest that neither PD-1 nor its ligands play a role as prognostic markers in non-clear cell RCC, while the prognostic role of PD-L2 in ccRCC as well as in non-clear cell RCC remains unclear.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (ER 795/1-1)
This publication has 29 references indexed in Scilit:
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II TrialJournal of Clinical Oncology, 2015
- The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinomaHuman Pathology, 2014
- PD-L1 expression in nonclear-cell renal cell carcinomaAnnals of Oncology, 2014
- PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor ResectionCancer Immunology Research, 2014
- Chromophobe renal cell carcinoma: A review of an uncommon entityInternational Journal of Urology, 2012
- IL-18 Induces PD-1–Dependent Immunosuppression in CancerCancer Research, 2011
- PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell CarcinomaClinical Cancer Research, 2007
- Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell CarcinomaClinical Cancer Research, 2007
- Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-upCancer Research, 2006
- Human chromophobe cell renal carcinomaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1985